- $18.7 BnWorld market, 2023
- $45.5 BnProjected, 2033
- 9.3%Growth a year (CAGR)
- 496Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$7.9 Bn
7.3% a year · 42% of the world -
2
China
$1.5 Bn
10.8% a year · 8% of the world -
3
Canada
$1.5 Bn
9.3% a year · 8% of the world -
4
Japan
$1.2 Bn
9.8% a year · 6.2% of the world -
5
Germany
$684 Mn
7.5% a year · 3.7% of the world -
6
France
$514 Mn
8.3% a year · 2.7% of the world -
7
UK
$486 Mn
7.3% a year · 2.6% of the world -
8
Brazil
$468 Mn
10.3% a year · 2.5% of the world -
9
Italy
$449 Mn
8.8% a year · 2.4% of the world -
10
Ecuador
$374 Mn
9.9% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
Mexico
SpainPoint Of Care (PoC) Molecular Diagnostic by country and region
India
Saudi Arabia
Australia
South Africa
UAE
Egypt
Philippines
Malaysia
Hong Kong
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 5,682 papers since 2021
- Finding the missing millions with tuberculosis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2026
- Smartphone-compatible visual detection of capsaicin via supramolecular assembly of carbon dots. Food chemistry, 2026
- Cost and operational impact of a molecular point-of-care test for sexually transmitted infections in the emergency department. The American journal of emergency medicine, 2026
- An integrated thin-film microfluidic point-of-care testing system for rapid detection of Ureaplasma urealyticum in cervical swabs. Infection, 2026
- Comparison of costs and health outcomes of mPOCT NEAR technology to PCR and LFD for influenza detection in the United Arab Emirates. IJID regions, 2026
Compare Point Of Care (PoC) Molecular Diagnostic side by side
Key companies in Point Of Care (PoC) Molecular Diagnostic
Roche Diagnostics
Cepheid
Thermo Fisher Scientific
bioMérieux
Quidel Corporation
Danaher Corporation
Siemens Healthineers
Hologic
Grifols
Quick answers
How big is the Point Of Care (PoC) Molecular Diagnostic market?
The world Point Of Care (PoC) Molecular Diagnostic market was worth about $18.7 Bn in 2023 and is projected to reach $45.5 Bn by 2033, growing 9.3% a year (CAGR).
Which country has the largest Point Of Care (PoC) Molecular Diagnostic market?
The US is the largest of the 24 countries we cover, at $7.9 Bn in 2023. India grows fastest, at 12.3% a year.
How many clinical trials are running in Point Of Care (PoC) Molecular Diagnostic?
ClinicalTrials.gov lists 496 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Point Of Care (PoC) Molecular Diagnostic?
PubMed lists about 5,682 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.